Filters

Article Type

384 Results

relevance


Enlifta

Ad Alert

Enlifta

FDA targets supplement sellers on Amazon making unapproved disease-treatment claims.

Blossom Nature

Ad Alert

Blossom Nature

FDA targets supplement sellers on Amazon making unapproved disease-treatment claims.

Skull Smash

Ad Alert

Skull Smash

FDA sniffs out unapproved claims company’s smelling salts increase alertness, focus, and more.

RiduZone

Ad Alert

RiduZone

Weight-loss supplement is sending mixed signals with its use of the FDA logo in a claim on its website that it is ‘FDA Acknowledged.’

Juul

Ad Alert

Juul

FDA zeros in on e-cigarette company’s marketing of flavors and their appeal to youth in an effort to curb underage use.

Discover CBD

Ad Alert

Discover CBD

Unapproved drug treatment claims remain in wake of FDA warning letter.

ZYTO Technologies

Ad Alert

ZYTO Technologies

FDA warning letter focuses on the ZYTO Hand Cradle, marketed as a medical diagnostic device.

Quietum Plus

Ad Alert

Quietum Plus

TINA.org finds several issues with marketing of purported tinnitus supplement.

That’s Natural

Ad Alert

That’s Natural

FDA reminds marijuana marketers that outing unproven treatment claims remains high on its list.

Vicaine

Ad Alert

Vicaine

FDA warns marketer of illegal tianeptine supplement about unapproved drug treatment claims.

Show More